Literature DB >> 18328359

Carnitine deficiency and L-carnitine supplementation in lysinuric protein intolerance.

Laura M Tanner1, Kirsti Näntö-Salonen, Mohamed S Rashed, Soile Kotilainen, Maija Aalto, Jaana Venetoklis, Harri Niinikoski, Kirsi Huoponen, Olli Simell.   

Abstract

The aim of the study was to investigate the prevalence and mechanisms of development of carnitine deficiency in patients with lysinuric protein intolerance (LPI). In our cohort of 37 Finnish patients with LPI, 8 (8-52 years of age) have been diagnosed with hypocarnitinemia. Their free and total serum carnitine levels, acyl carnitine profiles, renal function, diet, and medication were compared with the data from 8 age- and sex-matched patients with LPI not treated with carnitine supplementation. In patients with LPI, hypocarnitinemia was strongly associated with female sex, renal insufficiency, and the use of ammonia-scavenging drugs. Of the 8 hypocarnitinemic patients, 3 complained of muscle weakness, and their symptoms disappeared during carnitine supplementation. Oral lysine supplementation did not correct hypocarnitinemia in our patients. The patients with LPI are at considerable risk for carnitine deficiency. Supplementation of hypocarnitinemic LPI patients with oral L-carnitine improved serum total carnitine values, but the ratio of free and total carnitine remained subnormal in all supplemented patients except one. Furthermore, decreased ratio of free and total serum carnitine was common even in LPI patients with normal total serum carnitine concentration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18328359     DOI: 10.1016/j.metabol.2007.11.019

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

1.  Urine Beta2-Microglobulin Is an Early Marker of Renal Involvement in LPI.

Authors:  Mari Kärki; Kirsti Näntö-Salonen; Harri Niinikoski; Laura M Tanner
Journal:  JIMD Rep       Date:  2015-06-30

2.  Combined hyperlipidemia in patients with lysinuric protein intolerance.

Authors:  Laura M Tanner; Harri Niinikoski; Kirsti Näntö-Salonen; Olli Simell
Journal:  J Inherit Metab Dis       Date:  2010-02-23       Impact factor: 4.982

Review 3.  Overview of symptoms and treatment for lysinuric protein intolerance.

Authors:  Atsuko Noguchi; Tsutomu Takahashi
Journal:  J Hum Genet       Date:  2019-06-18       Impact factor: 3.172

4.  Environmental Enteric Dysfunction is Associated with Carnitine Deficiency and Altered Fatty Acid Oxidation.

Authors:  Richard D Semba; Indi Trehan; Ximin Li; Ruin Moaddel; M Isabel Ordiz; Kenneth M Maleta; Klaus Kraemer; Michelle Shardell; Luigi Ferrucci; Mark Manary
Journal:  EBioMedicine       Date:  2017-01-18       Impact factor: 8.143

5.  SP-D counteracts GM-CSF-mediated increase of granuloma formation by alveolar macrophages in lysinuric protein intolerance.

Authors:  David N Douda; Nicole Farmakovski; Sharon Dell; Hartmut Grasemann; Nades Palaniyar
Journal:  Orphanet J Rare Dis       Date:  2009-12-23       Impact factor: 4.123

6.  The Alteration of Carnitine Metabolism in Second Trimester in GDM and a Nomogram for Predicting Macrosomia.

Authors:  Man Sun; Baihui Zhao; Sainan He; Ruopeng Weng; Binqiao Wang; Yunping Ding; Xinwen Huang; Qiong Luo
Journal:  J Diabetes Res       Date:  2020-08-11       Impact factor: 4.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.